The South Australian immunoGENomics Cancer Institute (SAiGENCI) will be the state’s world-class cancer research institute, jointly resourced by an alliance of the Federal Department of Health, the Central Adelaide Local Health Network and the University of Adelaide. With an explicitly translational remit, the purpose of the new Institute is to focus on cancer research and clinical trials that will bring new cutting-edge technologies in immunotherapies and genomics to Adelaide. SAiGENCI will allow for coordinated collaboration in the fight to control cancer and explore a cure, by attracting and retaining brilliant biomedical and clinical researchers and collaborating externally with likeminded centres of excellence across the globe.
VIEWThe University of Adelaide is consistently ranked in the top 1% of the world’s universities. Recognised globally as a leading research university, it has a growing philanthropic profile and boundless opportunities to engage alumni and inspire donors in support of the University’s mission and strategy.
VIEWChildren’s Cancer Institute has seen significant progress and success in striving to achieve its mission of Zero Childhood Cancer. With its established track record in world-leading medical research into new, improved treatments for childhood cancer, it is now at a pivotal point of growth as it looks to open Australia’s first Children’s Comprehensive Cancer Centre as part of the Randwick Health and Innovation Precinct.
VIEW